Efatutazone Active Not Recruiting Phase 2 Trials for Anaplastic Thyroid Cancers / Recurrent Thyroid Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02152137Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer